BME/AME therapy(Hemogenyx)

N/A

Report date: 2024/12/09 10:09:24

Base Information

Drug NameBME/AME therapy(Hemogenyx)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasmsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHemogenyx Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesHemogenyx Pharmaceuticals PLC
Inactive CompaniesN/A
Active IndicationsNeoplasmsSevere Acute Respiratory Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A